Sam L. Teichman
Corporate Officer/Principal bei American College of Cardiology Foundation
Profil
Sam L.
Teichman is a Fellow at the American College of Cardiology Foundation and The European Society of Cardiology.
He previously worked as Director & Chief Medical Officer at BEAT BioTherapeutics Corp., Principal at Genentech, Inc., Acting Chief Medical Officer at KineMed, Inc., Senior Vice President-Research & Development at Corthera, Inc., Chief Medical Officer at Chiasma, Inc., and Chief Development Officer & Vice President at ARYx Therapeutics, Inc. He was also an Associate Clinical Professor at The University of California, San Francisco from 1990 to 2001 and a Fellow at the American College of Physicians, Inc. He received his undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Sam L. Teichman
| Unternehmen | Position | Beginn |
|---|---|---|
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
| The European Society of Cardiology | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sam L. Teichman
| Unternehmen | Position | Ende |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
BEAT BioTherapeutics Corp.
 BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| CHIASMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| KINEMED INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sam L. Teichman
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARYX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services KineMed, Inc. develops and commercializes biomarker platform technology. It provides dynamic proteomics platform, a functionally interpretable systems biology platform. The company was founded by David M. Fineman and Marc K. Hellerstein in February 2001 and is headquartered in Emeryville, CA. | Commercial Services |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
American College of Physicians, Inc. /Old/
 American College of Physicians, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services American College of Physicians, Inc. operates as a medical-specialty organization. It is a national organization of internists and physician specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and care of adults from health to complex illness. Its members include internists, internal medicine subspecialists, medical students, residents, and fellows. The company was founded in 1915 and is headquartered Philadelphia, PA. | Commercial Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Health Services |
| The European Society of Cardiology | |
BEAT BioTherapeutics Corp.
BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Health Technology |
